There are synergistic effects of Aβ and tau protein in Alzheimer's disease. Aβ 1−42 protofibril seeds induce conversion of human tau protein into β-sheet-rich toxic tau oligomers. However, the molecular mechanisms underlying such a conformational conversion are unclear. Here, we use extensive all atom replica exchange molecular dynamics simulations to investigate the effects of preformed Aβ 1−42 protofibril on two monomeric tau constructs: K18 and K19. We found that Aβ oligomer stretches tau conformation and drastically reduces the metastable secondary structures/hydrogen bonding/salt-bridge networks in tau monomers and exposes their fibril nucleating motifs 275 VQIINK 280 and 306 VQIVYK 311 . Aβ interacting patches around Tyr10/Ile41 contribute significantly to the interactions with K18 and K19. Aβ cross-seeded tau aggregation can adopt a "stretching-and-packing" mechanism, paving the way for the next, prion-like growth step. The results provide a mechanism on the atomic level to experimental observations that tau pathogenesis is promoted by Aβ 1−42 but not by Aβ 1−40 .A myloid β (Aβ) forms extracellular senile plaques and tau protein simultaneously forms intracellular neurofibrillary tangles (NFTs) in the brain of Alzheimer's disease patients. 1,2 There is increasing evidence of independent and synergistic effects of Aβ and tau. 3−5 Classically, Aβ and tau are respectively deposited extra-and intracellularly. However, Aβ also accumulates intraneuronally 2,6 and it binds to tau to form insoluble complexes within the same neurons. 7 In the Aβ-induced tau pathology, Aβ accumulation occurs prior to tau in AD pathogenesis and triggers the conversion of tau from normal to toxic states. 3,4,6,8−15 Although mechanisms linking Aβ and tau-pathology have not been conclusively identified, several potential mechanisms have been postulated. These posit that (1) Aβ interacts directly with neuronal receptors and membranes, (2) Aβ induces inflammation via glial cells, and (3) Aβ directly seeds and propagates tau aggregation. 4 The third mechanism has recently drawn increasing attention. 4,8,16−18 Propagation of toxic, misfolded Aβ and tau bears a striking resemblance to that of the prion protein. 16,17,19 Misfolded Aβ promotes tau aggregation in vitro through direct, intermolecular interaction. 15,20,21 Intriguingly, injection of preaggregated synthetic amyloid peptides 9 or aggregated amyloid peptide enriched brain extracts 22 induced tau aggregation not only at the injection site but also in functionally connected brain regions remote from the site, which indicates that amyloid peptides can initiate and propagate tau aggregation in these regions as well. 9,22 This prion-like behavior 23,24 of Aβ and tau underscores the need for an in-depth understanding of the seeding mechanism through which Aβ induces tau pathology.It has been shown that Aβ 1−42 oligomer seeds induce the conversion of unstructured, monomeric human recombinant tau into β-sheet-rich toxic tau oligomers. 20 Previous simulations of the interactions of Aβ fibri...